共 50 条
- [34] Utilizing Ceftazidime/Avibactam Therapeutic Drug Monitoring in the Treatment of Neurosurgical Meningitis Caused by Difficult-to-Treat Resistant Pseudomonas aeruginosa and KPC-Producing Enterobacterales OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11):
- [37] Draft Genome Sequence of the Extensively Drug-Resistant Pseudomonas aeruginosa Clinical Isolate TUEPA7472 MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2018, 7 (12):
- [38] Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs ANTIBIOTICS-BASEL, 2021, 10 (10):
- [39] The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings ANTIBIOTICS-BASEL, 2022, 11 (03):